Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

My Posts

Gene Therapy Restores Sight to Children Born Blind

By Orgesta Tolaj

|

29 April 2025

blind

© Moorfields Hospital

Imagine a world where children born blind can see for the first time. This isn’t a scene from a science fiction movie—it’s the reality for six-year-old Jace Broadbin from Connecticut.

Born with Leber congenital amaurosis (LCA), a rare genetic disorder affecting the AIPL1 gene, Jace’s life changed after undergoing groundbreaking gene therapy in London.

The Breakthrough Procedure

In a pioneering clinical trial at Moorfields Eye Hospital and Great Ormond Street Hospital, doctors performed a 60-minute keyhole surgery, injecting healthy copies of the AIPL1 gene directly into Jace’s retina. This gene is crucial for the function of photoreceptors, the cells in the eye responsible for detecting light.

blind
© Moorfields Hospital

Just weeks after the procedure, Jace’s parents noticed remarkable changes. One morning, sunlight streamed into their home, and Jace instinctively turned toward it, squinting—a reaction he had never exhibited before. This simple act signaled the beginning of his journey into the world of sight.

Beyond One Child

Jace wasn’t alone in this transformative experience. Three other children from Turkey, Tunisia, and the United States, all with the same genetic mutation, underwent the same treatment. Each showed significant improvements in vision, from recognizing faces to navigating their surroundings more confidently.

The success of this therapy lies in its timing. Administering the treatment between the ages of one and three allowed doctors to intervene before significant retinal damage occurred. Follow-up tests revealed that treated eyes had better visual acuity and preserved retinal structure compared to untreated eyes.

A Global Impact

Since the initial trial, seven more children have received the therapy at Evelina London Children’s Hospital. The results have been described as “hugely impressive,” offering hope to families worldwide and marking a potential paradigm shift in treating severe childhood blindness.

blind
© Moorfields Hospital

While this therapy isn’t a universal cure, it’s a monumental step forward. It showcases the power of persistence in scientific research and the profound impact such advancements can have on individuals’ lives. As gene therapy continues to evolve, stories like Jace’s illuminate the path toward a future where blindness from genetic conditions may become a thing of the past.

You might also want to read: Tooth-in-Eye Surgery: A Strange Procedure That Brings Back Sight

Orgesta Tolaj

Your favorite introvert who is buzzing around the Hive like a busy bee!

Share